{"transactions":[{"id":2179046,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":31448,"kind":"person","name":"FAIRBAIRN EMILY","position":1,"cik":"0001682638","reported_name":"FAIRBAIRN EMILY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124400,"kind":"organization","name":"Transcend Partners Opportunity Fund LLC","position":2,"cik":"0001832019","reported_name":"Transcend Partners Opportunity Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-18T20:17:29.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":789473,"price":1.9,"value":1499998.7,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities are held by Transcend Partners Opportunity Fund LLC (\"Transcend\"). Emily Fairbairn is the sole managing member of Transcend and has voting and investment power over the shares held by Transcend."}],"balance_after":4111958,"source":{"system":"sec-edgar","filing":"0001209191-22-046616","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682638/000120919122046616/doc4.xml","form_type":"4"}},{"id":2616692,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":31448,"kind":"person","name":"FAIRBAIRN EMILY","position":1,"cik":"0001682638","reported_name":"FAIRBAIRN EMILY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124400,"kind":"organization","name":"Transcend Partners Opportunity Fund LLC","position":2,"cik":"0001832019","reported_name":"Transcend Partners Opportunity Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-08-03T20:51:46.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":2930332,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Transcend Partners Opportunity Fund LLC (\"Transcend\"). Emily Fairbairn is the sole managing member of Transcend\nand has voting and investment power over the shares held by Transcend."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3222485},"source":{"system":"sec-edgar","filing":"0001209191-21-049368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1682638/000120919121049368/doc4.xml","form_type":"4"}},{"id":2616691,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":31448,"kind":"person","name":"FAIRBAIRN EMILY","position":1,"cik":"0001682638","reported_name":"FAIRBAIRN EMILY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124400,"kind":"organization","name":"Transcend Partners Opportunity Fund LLC","position":2,"cik":"0001832019","reported_name":"Transcend Partners Opportunity Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-08-03T20:51:46.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":25195,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held by Emily T. Fairbairn Roth IRA (\"Roth IRA\"). Emily Fairbairn exercises control over the Roth IRA, and as such, has voting\nand investment power over the shares held by the Roth IRA."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27706},"source":{"system":"sec-edgar","filing":"0001209191-21-049368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1682638/000120919121049368/doc4.xml","form_type":"4"}},{"id":2616690,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":31448,"kind":"person","name":"FAIRBAIRN EMILY","position":1,"cik":"0001682638","reported_name":"FAIRBAIRN EMILY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124400,"kind":"organization","name":"Transcend Partners Opportunity Fund LLC","position":2,"cik":"0001832019","reported_name":"Transcend Partners Opportunity Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-08-03T20:51:46.000Z","date":"2021-08-03","kind":"exercise","acquired":false,"shares":75588,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Valley High Limited Partnership (\"Valley High\"). Emily Fairbairn is the sole managing partner of Valley High and has\nvoting and investment power over the shares held by Valley High."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":83124},"source":{"system":"sec-edgar","filing":"0001209191-21-049368","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1682638/000120919121049368/doc4.xml","form_type":"4"}},{"id":2616689,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":31448,"kind":"person","name":"FAIRBAIRN EMILY","position":1,"cik":"0001682638","reported_name":"FAIRBAIRN EMILY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124400,"kind":"organization","name":"Transcend Partners Opportunity Fund LLC","position":2,"cik":"0001832019","reported_name":"Transcend Partners Opportunity Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T20:51:46.000Z","date":"2021-08-03","kind":"purchase","acquired":true,"shares":100000,"price":10,"value":1000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Transcend Partners Opportunity Fund LLC (\"Transcend\"). Emily Fairbairn is the sole managing member of Transcend\nand has voting and investment power over the shares held by Transcend."}],"balance_after":3322485,"source":{"system":"sec-edgar","filing":"0001209191-21-049368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1682638/000120919121049368/doc4.xml","form_type":"4"}},{"id":2616688,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":31448,"kind":"person","name":"FAIRBAIRN EMILY","position":1,"cik":"0001682638","reported_name":"FAIRBAIRN EMILY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124400,"kind":"organization","name":"Transcend Partners Opportunity Fund LLC","position":2,"cik":"0001832019","reported_name":"Transcend Partners Opportunity Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T20:51:46.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":3222485,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities are held by Transcend Partners Opportunity Fund LLC (\"Transcend\"). Emily Fairbairn is the sole managing member of Transcend\nand has voting and investment power over the shares held by Transcend."}],"balance_after":3222485,"source":{"system":"sec-edgar","filing":"0001209191-21-049368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1682638/000120919121049368/doc4.xml","form_type":"4"}},{"id":2616687,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":31448,"kind":"person","name":"FAIRBAIRN EMILY","position":1,"cik":"0001682638","reported_name":"FAIRBAIRN EMILY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124400,"kind":"organization","name":"Transcend Partners Opportunity Fund LLC","position":2,"cik":"0001832019","reported_name":"Transcend Partners Opportunity Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T20:51:46.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":27706,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held by Emily T. Fairbairn Roth IRA (\"Roth IRA\"). Emily Fairbairn exercises control over the Roth IRA, and as such, has voting\nand investment power over the shares held by the Roth IRA."}],"balance_after":27706,"source":{"system":"sec-edgar","filing":"0001209191-21-049368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682638/000120919121049368/doc4.xml","form_type":"4"}},{"id":2616686,"issuer":{"id":7941,"kind":"organization","name":"IN8BIO, INC."},"owners":[{"id":31448,"kind":"person","name":"FAIRBAIRN EMILY","position":1,"cik":"0001682638","reported_name":"FAIRBAIRN EMILY","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124400,"kind":"organization","name":"Transcend Partners Opportunity Fund LLC","position":2,"cik":"0001832019","reported_name":"Transcend Partners Opportunity Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T20:51:46.000Z","date":"2021-08-03","kind":"exercise","acquired":true,"shares":83124,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock was convertible at any time at the option of the holder, without payment of additional consideration, into\nCommon Stock, on a 1.0997 for 1 basis, had no expiration date and automatically converted into shares of Common Stock upon the\nclosing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Valley High Limited Partnership (\"Valley High\"). Emily Fairbairn is the sole managing partner of Valley High and has\nvoting and investment power over the shares held by Valley High."}],"balance_after":91336,"source":{"system":"sec-edgar","filing":"0001209191-21-049368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682638/000120919121049368/doc4.xml","form_type":"4"}}]}